Drug-Eluting Balloons-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Drug-Eluting Balloons-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Drug-Eluting Balloons industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Drug-Eluting Balloons 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Drug-Eluting Balloons worldwide and market share by regions, with company and product introduction, position in the Drug-Eluting Balloons market
Market status and development trend of Drug-Eluting Balloons by types and applications
Cost and profit status of Drug-Eluting Balloons, and marketing status
Market growth drivers and challenges
The report segments the global Drug-Eluting Balloons market as:
Global Drug-Eluting Balloons Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Drug-Eluting Balloons Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Semi-Compliant Balloons
Non-Compliant Balloons
Global Drug-Eluting Balloons Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Treatment of In-stent Restenosis (ISR)
Treatment of Small Vessel Disease (SVD)
Treatment of Bifurcation Stenoses
Treatment of Primary Coronary Artery Disease
Global Drug-Eluting Balloons Market: Manufacturers Segment Analysis (Company and Product introduction, Drug-Eluting Balloons Sales Volume, Revenue, Price and Gross Margin):
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Drug-Eluting Balloons-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Drug-Eluting Balloons industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Drug-Eluting Balloons 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Drug-Eluting Balloons worldwide and market share by regions, with company and product introduction, position in the Drug-Eluting Balloons market
Market status and development trend of Drug-Eluting Balloons by types and applications
Cost and profit status of Drug-Eluting Balloons, and marketing status
Market growth drivers and challenges
The report segments the global Drug-Eluting Balloons market as:
Global Drug-Eluting Balloons Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Drug-Eluting Balloons Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Semi-Compliant Balloons
Non-Compliant Balloons
Global Drug-Eluting Balloons Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Treatment of In-stent Restenosis (ISR)
Treatment of Small Vessel Disease (SVD)
Treatment of Bifurcation Stenoses
Treatment of Primary Coronary Artery Disease
Global Drug-Eluting Balloons Market: Manufacturers Segment Analysis (Company and Product introduction, Drug-Eluting Balloons Sales Volume, Revenue, Price and Gross Margin):
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF DRUG-ELUTING BALLOONS
1.1 Definition of Drug-Eluting Balloons in This Report
1.2 Commercial Types of Drug-Eluting Balloons
1.2.1 Semi-Compliant Balloons
1.2.2 Non-Compliant Balloons
1.3 Downstream Application of Drug-Eluting Balloons
1.3.1 Treatment of In-stent Restenosis (ISR)
1.3.2 Treatment of Small Vessel Disease (SVD)
1.3.3 Treatment of Bifurcation Stenoses
1.3.4 Treatment of Primary Coronary Artery Disease
1.4 Development History of Drug-Eluting Balloons
1.5 Market Status and Trend of Drug-Eluting Balloons 2013-2023
1.5.1 Global Drug-Eluting Balloons Market Status and Trend 2013-2023
1.5.2 Regional Drug-Eluting Balloons Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Drug-Eluting Balloons 2013-2017
2.2 Sales Market of Drug-Eluting Balloons by Regions
2.2.1 Sales Volume of Drug-Eluting Balloons by Regions
2.2.2 Sales Value of Drug-Eluting Balloons by Regions
2.3 Production Market of Drug-Eluting Balloons by Regions
2.4 Global Market Forecast of Drug-Eluting Balloons 2018-2023
2.4.1 Global Market Forecast of Drug-Eluting Balloons 2018-2023
2.4.2 Market Forecast of Drug-Eluting Balloons by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Drug-Eluting Balloons by Types
3.2 Sales Value of Drug-Eluting Balloons by Types
3.3 Market Forecast of Drug-Eluting Balloons by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Drug-Eluting Balloons by Downstream Industry
4.2 Global Market Forecast of Drug-Eluting Balloons by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Drug-Eluting Balloons Market Status by Countries
5.1.1 North America Drug-Eluting Balloons Sales by Countries (2013-2017)
5.1.2 North America Drug-Eluting Balloons Revenue by Countries (2013-2017)
5.1.3 United States Drug-Eluting Balloons Market Status (2013-2017)
5.1.4 Canada Drug-Eluting Balloons Market Status (2013-2017)
5.1.5 Mexico Drug-Eluting Balloons Market Status (2013-2017)
5.2 North America Drug-Eluting Balloons Market Status by Manufacturers
5.3 North America Drug-Eluting Balloons Market Status by Type (2013-2017)
5.3.1 North America Drug-Eluting Balloons Sales by Type (2013-2017)
5.3.2 North America Drug-Eluting Balloons Revenue by Type (2013-2017)
5.4 North America Drug-Eluting Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Drug-Eluting Balloons Market Status by Countries
6.1.1 Europe Drug-Eluting Balloons Sales by Countries (2013-2017)
6.1.2 Europe Drug-Eluting Balloons Revenue by Countries (2013-2017)
6.1.3 Germany Drug-Eluting Balloons Market Status (2013-2017)
6.1.4 UK Drug-Eluting Balloons Market Status (2013-2017)
6.1.5 France Drug-Eluting Balloons Market Status (2013-2017)
6.1.6 Italy Drug-Eluting Balloons Market Status (2013-2017)
6.1.7 Russia Drug-Eluting Balloons Market Status (2013-2017)
6.1.8 Spain Drug-Eluting Balloons Market Status (2013-2017)
6.1.9 Benelux Drug-Eluting Balloons Market Status (2013-2017)
6.2 Europe Drug-Eluting Balloons Market Status by Manufacturers
6.3 Europe Drug-Eluting Balloons Market Status by Type (2013-2017)
6.3.1 Europe Drug-Eluting Balloons Sales by Type (2013-2017)
6.3.2 Europe Drug-Eluting Balloons Revenue by Type (2013-2017)
6.4 Europe Drug-Eluting Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Drug-Eluting Balloons Market Status by Countries
7.1.1 Asia Pacific Drug-Eluting Balloons Sales by Countries (2013-2017)
7.1.2 Asia Pacific Drug-Eluting Balloons Revenue by Countries (2013-2017)
7.1.3 China Drug-Eluting Balloons Market Status (2013-2017)
7.1.4 Japan Drug-Eluting Balloons Market Status (2013-2017)
7.1.5 India Drug-Eluting Balloons Market Status (2013-2017)
7.1.6 Southeast Asia Drug-Eluting Balloons Market Status (2013-2017)
7.1.7 Australia Drug-Eluting Balloons Market Status (2013-2017)
7.2 Asia Pacific Drug-Eluting Balloons Market Status by Manufacturers
7.3 Asia Pacific Drug-Eluting Balloons Market Status by Type (2013-2017)
7.3.1 Asia Pacific Drug-Eluting Balloons Sales by Type (2013-2017)
7.3.2 Asia Pacific Drug-Eluting Balloons Revenue by Type (2013-2017)
7.4 Asia Pacific Drug-Eluting Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Drug-Eluting Balloons Market Status by Countries
8.1.1 Latin America Drug-Eluting Balloons Sales by Countries (2013-2017)
8.1.2 Latin America Drug-Eluting Balloons Revenue by Countries (2013-2017)
8.1.3 Brazil Drug-Eluting Balloons Market Status (2013-2017)
8.1.4 Argentina Drug-Eluting Balloons Market Status (2013-2017)
8.1.5 Colombia Drug-Eluting Balloons Market Status (2013-2017)
8.2 Latin America Drug-Eluting Balloons Market Status by Manufacturers
8.3 Latin America Drug-Eluting Balloons Market Status by Type (2013-2017)
8.3.1 Latin America Drug-Eluting Balloons Sales by Type (2013-2017)
8.3.2 Latin America Drug-Eluting Balloons Revenue by Type (2013-2017)
8.4 Latin America Drug-Eluting Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Drug-Eluting Balloons Market Status by Countries
9.1.1 Middle East and Africa Drug-Eluting Balloons Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Drug-Eluting Balloons Revenue by Countries (2013-2017)
9.1.3 Middle East Drug-Eluting Balloons Market Status (2013-2017)
9.1.4 Africa Drug-Eluting Balloons Market Status (2013-2017)
9.2 Middle East and Africa Drug-Eluting Balloons Market Status by Manufacturers
9.3 Middle East and Africa Drug-Eluting Balloons Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Drug-Eluting Balloons Sales by Type (2013-2017)
9.3.2 Middle East and Africa Drug-Eluting Balloons Revenue by Type (2013-2017)
9.4 Middle East and Africa Drug-Eluting Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF DRUG-ELUTING BALLOONS
10.1 Global Economy Situation and Trend Overview
10.2 Drug-Eluting Balloons Downstream Industry Situation and Trend Overview
CHAPTER 11 DRUG-ELUTING BALLOONS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Drug-Eluting Balloons by Major Manufacturers
11.2 Production Value of Drug-Eluting Balloons by Major Manufacturers
11.3 Basic Information of Drug-Eluting Balloons by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Drug-Eluting Balloons Major Manufacturer
11.3.2 Employees and Revenue Level of Drug-Eluting Balloons Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 DRUG-ELUTING BALLOONS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Boston Scientific
12.1.1 Company profile
12.1.2 Representative Drug-Eluting Balloons Product
12.1.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Boston Scientific
12.2 Medtronic
12.2.1 Company profile
12.2.2 Representative Drug-Eluting Balloons Product
12.2.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Medtronic
12.3 Cook Medical
12.3.1 Company profile
12.3.2 Representative Drug-Eluting Balloons Product
12.3.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Cook Medical
12.4 C.R. Bard
12.4.1 Company profile
12.4.2 Representative Drug-Eluting Balloons Product
12.4.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of C.R. Bard
12.5 B. Braun
12.5.1 Company profile
12.5.2 Representative Drug-Eluting Balloons Product
12.5.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of B. Braun
12.6 Eurocor GmbH
12.6.1 Company profile
12.6.2 Representative Drug-Eluting Balloons Product
12.6.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Eurocor GmbH
12.7 Blue Medical
12.7.1 Company profile
12.7.2 Representative Drug-Eluting Balloons Product
12.7.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Blue Medical
12.8 Bayer
12.8.1 Company profile
12.8.2 Representative Drug-Eluting Balloons Product
12.8.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Bayer
12.9 Aachen Resonance
12.9.1 Company profile
12.9.2 Representative Drug-Eluting Balloons Product
12.9.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Aachen Resonance
12.10 Acrostak
12.10.1 Company profile
12.10.2 Representative Drug-Eluting Balloons Product
12.10.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Acrostak
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG-ELUTING BALLOONS
13.1 Industry Chain of Drug-Eluting Balloons
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF DRUG-ELUTING BALLOONS
14.1 Cost Structure Analysis of Drug-Eluting Balloons
14.2 Raw Materials Cost Analysis of Drug-Eluting Balloons
14.3 Labor Cost Analysis of Drug-Eluting Balloons
14.4 Manufacturing Expenses Analysis of Drug-Eluting Balloons
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Drug-Eluting Balloons in This Report
1.2 Commercial Types of Drug-Eluting Balloons
1.2.1 Semi-Compliant Balloons
1.2.2 Non-Compliant Balloons
1.3 Downstream Application of Drug-Eluting Balloons
1.3.1 Treatment of In-stent Restenosis (ISR)
1.3.2 Treatment of Small Vessel Disease (SVD)
1.3.3 Treatment of Bifurcation Stenoses
1.3.4 Treatment of Primary Coronary Artery Disease
1.4 Development History of Drug-Eluting Balloons
1.5 Market Status and Trend of Drug-Eluting Balloons 2013-2023
1.5.1 Global Drug-Eluting Balloons Market Status and Trend 2013-2023
1.5.2 Regional Drug-Eluting Balloons Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Drug-Eluting Balloons 2013-2017
2.2 Sales Market of Drug-Eluting Balloons by Regions
2.2.1 Sales Volume of Drug-Eluting Balloons by Regions
2.2.2 Sales Value of Drug-Eluting Balloons by Regions
2.3 Production Market of Drug-Eluting Balloons by Regions
2.4 Global Market Forecast of Drug-Eluting Balloons 2018-2023
2.4.1 Global Market Forecast of Drug-Eluting Balloons 2018-2023
2.4.2 Market Forecast of Drug-Eluting Balloons by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Drug-Eluting Balloons by Types
3.2 Sales Value of Drug-Eluting Balloons by Types
3.3 Market Forecast of Drug-Eluting Balloons by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Drug-Eluting Balloons by Downstream Industry
4.2 Global Market Forecast of Drug-Eluting Balloons by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Drug-Eluting Balloons Market Status by Countries
5.1.1 North America Drug-Eluting Balloons Sales by Countries (2013-2017)
5.1.2 North America Drug-Eluting Balloons Revenue by Countries (2013-2017)
5.1.3 United States Drug-Eluting Balloons Market Status (2013-2017)
5.1.4 Canada Drug-Eluting Balloons Market Status (2013-2017)
5.1.5 Mexico Drug-Eluting Balloons Market Status (2013-2017)
5.2 North America Drug-Eluting Balloons Market Status by Manufacturers
5.3 North America Drug-Eluting Balloons Market Status by Type (2013-2017)
5.3.1 North America Drug-Eluting Balloons Sales by Type (2013-2017)
5.3.2 North America Drug-Eluting Balloons Revenue by Type (2013-2017)
5.4 North America Drug-Eluting Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Drug-Eluting Balloons Market Status by Countries
6.1.1 Europe Drug-Eluting Balloons Sales by Countries (2013-2017)
6.1.2 Europe Drug-Eluting Balloons Revenue by Countries (2013-2017)
6.1.3 Germany Drug-Eluting Balloons Market Status (2013-2017)
6.1.4 UK Drug-Eluting Balloons Market Status (2013-2017)
6.1.5 France Drug-Eluting Balloons Market Status (2013-2017)
6.1.6 Italy Drug-Eluting Balloons Market Status (2013-2017)
6.1.7 Russia Drug-Eluting Balloons Market Status (2013-2017)
6.1.8 Spain Drug-Eluting Balloons Market Status (2013-2017)
6.1.9 Benelux Drug-Eluting Balloons Market Status (2013-2017)
6.2 Europe Drug-Eluting Balloons Market Status by Manufacturers
6.3 Europe Drug-Eluting Balloons Market Status by Type (2013-2017)
6.3.1 Europe Drug-Eluting Balloons Sales by Type (2013-2017)
6.3.2 Europe Drug-Eluting Balloons Revenue by Type (2013-2017)
6.4 Europe Drug-Eluting Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Drug-Eluting Balloons Market Status by Countries
7.1.1 Asia Pacific Drug-Eluting Balloons Sales by Countries (2013-2017)
7.1.2 Asia Pacific Drug-Eluting Balloons Revenue by Countries (2013-2017)
7.1.3 China Drug-Eluting Balloons Market Status (2013-2017)
7.1.4 Japan Drug-Eluting Balloons Market Status (2013-2017)
7.1.5 India Drug-Eluting Balloons Market Status (2013-2017)
7.1.6 Southeast Asia Drug-Eluting Balloons Market Status (2013-2017)
7.1.7 Australia Drug-Eluting Balloons Market Status (2013-2017)
7.2 Asia Pacific Drug-Eluting Balloons Market Status by Manufacturers
7.3 Asia Pacific Drug-Eluting Balloons Market Status by Type (2013-2017)
7.3.1 Asia Pacific Drug-Eluting Balloons Sales by Type (2013-2017)
7.3.2 Asia Pacific Drug-Eluting Balloons Revenue by Type (2013-2017)
7.4 Asia Pacific Drug-Eluting Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Drug-Eluting Balloons Market Status by Countries
8.1.1 Latin America Drug-Eluting Balloons Sales by Countries (2013-2017)
8.1.2 Latin America Drug-Eluting Balloons Revenue by Countries (2013-2017)
8.1.3 Brazil Drug-Eluting Balloons Market Status (2013-2017)
8.1.4 Argentina Drug-Eluting Balloons Market Status (2013-2017)
8.1.5 Colombia Drug-Eluting Balloons Market Status (2013-2017)
8.2 Latin America Drug-Eluting Balloons Market Status by Manufacturers
8.3 Latin America Drug-Eluting Balloons Market Status by Type (2013-2017)
8.3.1 Latin America Drug-Eluting Balloons Sales by Type (2013-2017)
8.3.2 Latin America Drug-Eluting Balloons Revenue by Type (2013-2017)
8.4 Latin America Drug-Eluting Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Drug-Eluting Balloons Market Status by Countries
9.1.1 Middle East and Africa Drug-Eluting Balloons Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Drug-Eluting Balloons Revenue by Countries (2013-2017)
9.1.3 Middle East Drug-Eluting Balloons Market Status (2013-2017)
9.1.4 Africa Drug-Eluting Balloons Market Status (2013-2017)
9.2 Middle East and Africa Drug-Eluting Balloons Market Status by Manufacturers
9.3 Middle East and Africa Drug-Eluting Balloons Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Drug-Eluting Balloons Sales by Type (2013-2017)
9.3.2 Middle East and Africa Drug-Eluting Balloons Revenue by Type (2013-2017)
9.4 Middle East and Africa Drug-Eluting Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF DRUG-ELUTING BALLOONS
10.1 Global Economy Situation and Trend Overview
10.2 Drug-Eluting Balloons Downstream Industry Situation and Trend Overview
CHAPTER 11 DRUG-ELUTING BALLOONS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Drug-Eluting Balloons by Major Manufacturers
11.2 Production Value of Drug-Eluting Balloons by Major Manufacturers
11.3 Basic Information of Drug-Eluting Balloons by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Drug-Eluting Balloons Major Manufacturer
11.3.2 Employees and Revenue Level of Drug-Eluting Balloons Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 DRUG-ELUTING BALLOONS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Boston Scientific
12.1.1 Company profile
12.1.2 Representative Drug-Eluting Balloons Product
12.1.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Boston Scientific
12.2 Medtronic
12.2.1 Company profile
12.2.2 Representative Drug-Eluting Balloons Product
12.2.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Medtronic
12.3 Cook Medical
12.3.1 Company profile
12.3.2 Representative Drug-Eluting Balloons Product
12.3.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Cook Medical
12.4 C.R. Bard
12.4.1 Company profile
12.4.2 Representative Drug-Eluting Balloons Product
12.4.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of C.R. Bard
12.5 B. Braun
12.5.1 Company profile
12.5.2 Representative Drug-Eluting Balloons Product
12.5.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of B. Braun
12.6 Eurocor GmbH
12.6.1 Company profile
12.6.2 Representative Drug-Eluting Balloons Product
12.6.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Eurocor GmbH
12.7 Blue Medical
12.7.1 Company profile
12.7.2 Representative Drug-Eluting Balloons Product
12.7.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Blue Medical
12.8 Bayer
12.8.1 Company profile
12.8.2 Representative Drug-Eluting Balloons Product
12.8.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Bayer
12.9 Aachen Resonance
12.9.1 Company profile
12.9.2 Representative Drug-Eluting Balloons Product
12.9.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Aachen Resonance
12.10 Acrostak
12.10.1 Company profile
12.10.2 Representative Drug-Eluting Balloons Product
12.10.3 Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin of Acrostak
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG-ELUTING BALLOONS
13.1 Industry Chain of Drug-Eluting Balloons
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF DRUG-ELUTING BALLOONS
14.1 Cost Structure Analysis of Drug-Eluting Balloons
14.2 Raw Materials Cost Analysis of Drug-Eluting Balloons
14.3 Labor Cost Analysis of Drug-Eluting Balloons
14.4 Manufacturing Expenses Analysis of Drug-Eluting Balloons
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
